DK0840609T3 - Anvendelse af usubstituerede og substituerede N-(pyrrol-1-yl)pyridinaminer som antikonvulsive midler - Google Patents

Anvendelse af usubstituerede og substituerede N-(pyrrol-1-yl)pyridinaminer som antikonvulsive midler

Info

Publication number
DK0840609T3
DK0840609T3 DK96923693T DK96923693T DK0840609T3 DK 0840609 T3 DK0840609 T3 DK 0840609T3 DK 96923693 T DK96923693 T DK 96923693T DK 96923693 T DK96923693 T DK 96923693T DK 0840609 T3 DK0840609 T3 DK 0840609T3
Authority
DK
Denmark
Prior art keywords
pyridinamines
anticonvulsants
pyrrol
unsubstituted
substituted
Prior art date
Application number
DK96923693T
Other languages
Danish (da)
English (en)
Inventor
Francis P Huger
Sathapana Kongsamut
Craig P Smith
Lei Tang
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Application granted granted Critical
Publication of DK0840609T3 publication Critical patent/DK0840609T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK96923693T 1995-07-27 1996-07-08 Anvendelse af usubstituerede og substituerede N-(pyrrol-1-yl)pyridinaminer som antikonvulsive midler DK0840609T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50807195A 1995-07-27 1995-07-27
PCT/US1996/011408 WO1997004777A1 (en) 1995-07-27 1996-07-08 Use off unsubstituted and substituted n-(pyrrol-1-yl)pyridinamines as anticonvulsant agents

Publications (1)

Publication Number Publication Date
DK0840609T3 true DK0840609T3 (da) 2002-09-30

Family

ID=24021262

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96923693T DK0840609T3 (da) 1995-07-27 1996-07-08 Anvendelse af usubstituerede og substituerede N-(pyrrol-1-yl)pyridinaminer som antikonvulsive midler

Country Status (20)

Country Link
EP (1) EP0840609B1 (no)
JP (1) JP4189029B2 (no)
KR (1) KR100445629B1 (no)
CN (1) CN1184969C (no)
AR (1) AR003471A1 (no)
AT (1) ATE218343T1 (no)
AU (1) AU696007B2 (no)
CA (1) CA2225156C (no)
DE (1) DE69621617T2 (no)
DK (1) DK0840609T3 (no)
ES (1) ES2174081T3 (no)
HK (1) HK1015687A1 (no)
IL (1) IL122845A0 (no)
MX (1) MX9800774A (no)
NO (1) NO315148B1 (no)
NZ (1) NZ312577A (no)
PT (1) PT840609E (no)
TW (1) TW464497B (no)
WO (1) WO1997004777A1 (no)
ZA (1) ZA966254B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GT200500063A (es) * 2004-04-01 2005-10-14 Metodo para tratar la esquizofrenia y/o anormalidades glucoregulatorias
FR2897614B1 (fr) * 2006-02-20 2008-05-23 Urogene Forme cristalline du chlorhydrate de la besipirdine, procedes de preparation et utilisations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5032599A (en) * 1986-11-12 1991-07-16 Hoechst-Roussel Pharmaceuticals Inc. N-(pyrrol-l-yl)pyridinamines
EP0287982B1 (en) * 1987-04-24 1994-12-07 Hoechst-Roussel Pharmaceuticals Incorporated N-(Pyridinyl)-1H-indol-1-amines, a process for their preparation and their use as medicaments
US4868190A (en) * 1988-12-27 1989-09-19 Hoechst-Roussel Pharmaceuticals, Inc. N-pyridinyl-9H-carbazol-9-amines
US5179099A (en) * 1989-08-02 1993-01-12 Hoechst-Roussel Pharmaceuticals Incorporated 2,3-dihydro-1-(pyridinylamino)-indoles
US5356910A (en) * 1993-07-19 1994-10-18 Hoechst-Roussel Pharmaceuticals Inc. Use of N-(pyridinyl)-1H-indol-1-amines for the treatment of obsessive-compulsive disorder

Also Published As

Publication number Publication date
CN1191486A (zh) 1998-08-26
IL122845A0 (en) 1998-08-16
NO980334L (no) 1998-03-26
AU6454796A (en) 1997-02-26
CA2225156C (en) 2003-06-10
HK1015687A1 (en) 1999-10-22
KR19990035973A (ko) 1999-05-25
EP0840609A1 (en) 1998-05-13
NO315148B1 (no) 2003-07-21
CA2225156A1 (en) 1997-02-13
JP4189029B2 (ja) 2008-12-03
ATE218343T1 (de) 2002-06-15
PT840609E (pt) 2002-10-31
JPH11510159A (ja) 1999-09-07
ZA966254B (en) 1997-02-11
AR003471A1 (es) 1998-08-05
AU696007B2 (en) 1998-08-27
ES2174081T3 (es) 2002-11-01
CN1184969C (zh) 2005-01-19
DE69621617T2 (de) 2003-01-02
DE69621617D1 (de) 2002-07-11
WO1997004777A1 (en) 1997-02-13
NO980334D0 (no) 1998-01-26
MX9800774A (es) 1998-04-30
KR100445629B1 (ko) 2004-10-14
EP0840609B1 (en) 2002-06-05
NZ312577A (en) 1999-08-30
TW464497B (en) 2001-11-21

Similar Documents

Publication Publication Date Title
NO961664L (no) Substituerte N-(indol-2-karbonyl)-glycinamider og derivater som anti-diabetiske midler
DK0832061T3 (da) Benzamidderivater og anvendelse deraf som vasopressin-antagonister
NO962322L (no) Substituerte N-(indol-2-karbonyl)--alanimamider og derivater som antidiabetiske midler
LV11178A (lv) 3-Ú4-(2-aminoetoksi) benzoil¾-2-aril-6-hidroksibenzoÚb¾tiofenu sintezes panemiens
DK0815861T3 (da) Sulfonamider og anvendelse deraf
DK0731099T3 (da) N-(3-Benzofuranyl)urinstof-derivater
ID17275A (id) N-[4-(heteroarilmetil)fenil]-heteroarilamina
NO982732D0 (no) Ny fremgangsmÕte
DK0804078T3 (da) Sammensætning og anvendelse deraf
NO961346D0 (no) Benzonitriler og benzofluorider
DE69429147T2 (de) Benzamidderivate
NO985891D0 (no) Substituerte benzamid-derivater og deres anvendelse som antikonvulsjonsmidler
NO305251B1 (no) Benzamidderivater
NO20003142D0 (no) Substituerte isokinolin-derivater og anvendelse derav som antikrampemidler
BR9710322A (pt) Tioamidas N-(5-isotiazolil) substituidas
DK0840609T3 (da) Anvendelse af usubstituerede og substituerede N-(pyrrol-1-yl)pyridinaminer som antikonvulsive midler
NO983556D0 (no) Formulering og anvendelse
BR9606610A (pt) Herbicidas n-(1-etil-4-pirazolil) triazolazinasulfonamida
DK0752511T3 (da) Hængsel og hængselfastgørelse
NO20001176D0 (no) Anvendelse av blandinger av polymerer og aminoisothiasoler som biocider
NO963939D0 (no) N-aryl og N-alkylsulfonylaminaler som pesticider
DE69529117D1 (de) Satz von miteinander gelenkig verbundenen Elementen
DE69703422D1 (de) Herstellung von Aminophenolen
DE59603388D1 (de) Anilinderivate
UA644S (uk) Мікро-еом широкого призначення